Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
21st Century Cures Act
Biotech
FDA lays out cell therapy fast track in regenerative medicine
The framework builds on the 21st Century Cures Act by setting criteria for the RMAT designation and outlining the benefits of the regulatory status.
Nick Paul Taylor
Nov 17, 2017 8:04am
Parexel launches dedicated real-world data service team
Sep 7, 2017 8:57am
FDA outlines ‘Innovation Initiative,’ Cures plans
Jul 10, 2017 8:10am
Parexel launches remote clinical trial data collection services
Apr 4, 2017 10:25am
What will Cures mean for biopharma R&D?
Dec 22, 2016 5:46am
Meet adaptive pathways—the EU counterpart of 21st Century Cures
Dec 19, 2016 4:07pm
